Comment on 'Bevacizumab vs ranibizumab for age-related macular degeneration: 1-year outcomes of a prospective, double-masked randomised clinical trial'
- PMID: 21350573
- PMCID: PMC3178136
- DOI: 10.1038/eye.2011.18
Comment on 'Bevacizumab vs ranibizumab for age-related macular degeneration: 1-year outcomes of a prospective, double-masked randomised clinical trial'
Comment on
-
Bevacizumab vs ranibizumab for age-related macular degeneration: 1-year outcomes of a prospective, double-masked randomised clinical trial.Eye (Lond). 2010 Nov;24(11):1708-15. doi: 10.1038/eye.2010.147. Epub 2010 Oct 1. Eye (Lond). 2010. PMID: 20885427 Clinical Trial.
References
-
- Subramanian ML, Abedi G, Ness S, Ahmed E, Fenberg M, Daly MK, et al. Bevacizumab vs ranibizumab for age-related macular degeneration: 1-year outcomes of a prospective, double-masked randomised clinical trial. Eye. 2010;24:1708–1715. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical